tender for e-bid for rate contract cum supply and empanelment of firms for drugs and medicines , cyclophosphamide inj ip 200 mg [138] , fluorouracil inj ip 250 mg/ 5ml [148] , methotrexate tab ip 2.5 mg [154] , vincristine injection ip 1 mg [159] , atropine eye ointment ip 1% [319] , ciprofloxacin ophthalmic ointment usp 0.3% [323] , inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724] , 3rd generation recombinant f viii 250 iu with diluent [749] , leurprolide acetate depot 3.75 mg [775] , gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103] , hpmc 0.3% eye drop [nrd-104] , voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119] , chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123] , carmustine 100 mg inj. ip [nrd-175] , detemir insuline 100iu/ml injection 3ml [nrd-214] , fludarabine phosphate injection 100mg inj. ip [nrd-237] , fludarabine phosphate injection 50mg inj. ip [nrd-238] , methotrexate 1000 mg inj. ip [nrd-289] , inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292] , mitomycin 40 mg inj. ip [nrd- 297] , plerixafor 24 mg inj. [nrd-338] , rasburicase 1.5 mg inj. [nrd-347] , recombinant lh 75iu inj. [nrd-351] , trabectedin 1 mg inj. [nrd- 387] , trypan blue 0.06% w/v injection [nrd-393] , levosalbutamol 50mcg. and ipratropium 40mcg. mdi [nrd-425] , glycopyrronium inhalation solution 25mcg 2 ml [nrd-458] , amorolfine 0.25% cream [nrd-46] , glycolic acid 6% cream [nrd-51] , hydroquinone 2% cream usp [nrd-53] , everolimus 10mg tab./cap. [nrd-531] , dacomitinib 15 mg tab. , methimazole 10mg tab. usp [nrd-678] , rasagiline1mg tab. [nrd-756] , regorafenib 40 mg tab. [nrd- 757] , ulipristal 5mg tab. [nrd-808] , brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98] , triclofos oral suspension500 mg/ 5ml in 30ml syrup i.p. [nrd-522] , etoricoxib+thiocolchicoside(6